Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jan. 31, 2026	Feb. 01, 2025
Cash flows from operating activities:
Net income	$ 303,177	$ 15,595
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	18,783	14,281
Share-based compensation	132,939	49,493
Warrant contra revenue	0	13,186
Write-downs for excess and obsolete inventory	11,831	4,353
Changes in operating assets and liabilities:
Accounts receivable	(81,069)	(97,471)
Inventories	(127,879)	(31,677)
Other current assets	(3,687)	5,115
Other non-current assets	(20,830)	1,628
Accounts payable	36,303	22,343
Accrued compensation and benefits, other current liabilities and other non-current liabilities	12,482	10,415
Net cash provided by operating activities	282,050	7,261
Cash flows from investing activities:
Purchases of property and equipment	(52,523)	(32,406)
Maturities of short-term investments	229,010	376,777
Purchases of short-term investments	(115,000)	(113,716)
Business acquisition, net of cash acquired	(82,564)	0
Net cash (used in) provided by investing activities	(21,077)	230,655
Cash flows from financing activities:
Payments on technology license obligations	(5,718)	(5,394)
Proceeds from ordinary shares issued under At-The-Market Offering, net of issuance costs	736,327	0
Proceeds from employee share incentive plans	6,599	6,797
Tax withheld related to RSU settlement	(14,250)	(7,159)
Net cash provided by (used in) financing activities	722,958	(5,756)
Effect of exchange rate changes on cash	205	106
Net increase in cash and cash equivalents	984,136	232,266
Cash and cash equivalents at beginning of the period	236,328	66,942
Cash and cash equivalents at end of the period	1,220,464	299,208
Supplemental cash flow information:
Purchases of property and equipment included in accounts payable, other current liabilities and other non-current liabilities	$ 7,029	$ 8,841